These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8104388)

  • 1. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry.
    Linden MD; Ma CK; Kubus J; Brown RD; Zarbo RJ
    Am J Clin Pathol; 1993 Sep; 100(3):206-12. PubMed ID: 8104388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer.
    Visscher DW; Wykes S; Kubus J; Crissman JD
    Breast Cancer Res Treat; 1992; 22(2):111-8. PubMed ID: 1356517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
    Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
    Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytometric ploidy and proliferative activity in colorectal carcinoma.
    Grigolato P; Berenzi A; Benetti A; Chirico E; Cadei M; Casella C; Salerni B; Lojacono L
    Eur J Histochem; 1994; 38(2):163-70. PubMed ID: 7524813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA content and cell kinetics in colorectal carcinoma: flow cytometric analysis of primary tumor and liver metastases.
    Danova M; De Renzis MR; Girino M; Valenti L; Mora O; Scabini M; Mazzini G; Riccardi A
    Tumori; 1995; 81(3 Suppl):12-5. PubMed ID: 7571041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas.
    Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG
    Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
    Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival.
    Enker WE; Kimmel M; Cibas ES; Cranor ML; Melamed MR
    J Natl Cancer Inst; 1991 May; 83(10):701-7. PubMed ID: 2023271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of bivariate cytokeratin and DNA flow cytometry in paraffin-embedded specimens of non-small cell lung cancer.
    Otsuka H; Funai S; Tsuda H; Azumi T; Hara S; Okuno K; Yasutomi M
    Int J Clin Oncol; 2001 Oct; 6(5):229-35. PubMed ID: 11723744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
    Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
    APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
    Steck K; el-Naggar AK
    Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of (S+G2)-phase fractions determined by flow cytometry and Ki-67 labelling indices in colorectal carcinomas.
    Zölzer F; Gilbertz K; Streffer C
    Oncology; 1994; 51(1):9-12. PubMed ID: 8265111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
    Dawson AE; Norton JA; Weinberg DS
    Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis.
    Ito M; Tsurusawa M; Zha Z; Kawai S; Takasaki Y; Fujimoto T
    Cancer; 1992 Apr; 69(8):2176-82. PubMed ID: 1347483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas.
    Wilson MS; Anderson E; Bell JC; Pearson JM; Haboubi NY; James RD; Schofield PF
    Surg Oncol; 1994 Oct; 3(5):263-73. PubMed ID: 7889219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.